Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31790561.
- Also identified by DOI 10.1001/jamanetworkopen.2019.16326 and PMC identifier 6902749.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study describes patterns of development, management strategies, and long-term vascular consequences of hypertension associated with ibrutinib in the non–clinical trial setting.
Medical subject headings
- Antihypertensive Agents
- Hypertension
- Leukemia, Lymphocytic, Chronic, B-Cell
- Pyrazoles
- Pyrimidines